Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|January 31, 2008
Glucokinase activators in diabetes managementMatthew Coghlan, Brendan LeightonAmerican Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 29, 2016
Dietary fat and corticosterone levels are contributing factors to meal anticipationSara Namvar, Amy Gyte, Mark Denn, et al.The Journal of Physiology|June 13, 2017
Muscle carnitine availability plays a central role in regulating fuel metabolism in the rodentCraig Porter, Dumitru Constantin-Teodosiu, Despina Constantin, et al.European Journal of Pharmacology|May 19, 2011
Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed miceMaria Sörhede Winzell, Matthew Coghlan, Brendan Leighton, et al.Diabetes|July 30, 2002
Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heartMartin E Young, Patrick H Guthrie, Peter Razeghi, et al.Journal of Diabetes Research|October 25, 2016
Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout MiceDamilola D Adingupu, Suvi E Heinonen, Anne-Christine Andréasson, et al.Endocrinology|July 9, 2013
11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male miceErika Harno, Elizabeth C Cottrell, Brian G Keevil, et al.Diabetes|February 28, 2004
Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activatorsKaty J Brocklehurst, Victoria A Payne, Rick A Davies, et al.Endocrinology|October 31, 2013
11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanismsErika Harno, Elizabeth C Cottrell, Alice Yu, et al.Journal of Diabetes Research|April 6, 2019
The APOE<sup>∗</sup>3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic AtherosclerosisMarianne G Pouwer, Suvi E Heinonen, Margareta Behrendt, et al.Pageof 2